Clostridial Myositis, Necrotizing Fasciitis, and Zygomycotic Infections

Physiology and Medicine of Hyperbaric Oxygen Therapy

Volumn , Issue , 2008, Pages 397-418

  Jacoby, Irving ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 71049122663     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3406-3.50023-8     Document Type: Chapter

References (109)

1. DJ Bakker (1988) Clostridial myonecrosis. JC Davis, TK Hunt (Eds) Problem Wounds: The Role of Oxygen New York: Elsevier Science Publishing 153-172
2. LDS Smith and BL Williams (1984) The Pathogenic Anaerobic Bacteria 3rd ed Springfield, IL: Charles C. Thomas Publishers 101-114
3. CH Chi, KW Chen, JJ Huang, et al. (1995) Gas composition in Clostridium septicum gas gangrene. J Formosa Med Assoc 94 757-759
4. PW Brown and PR Kinman (1974) Gas gangrene in a metropolitan community. J Bone Joint Surg 56A 1445-1451
5. RF Bellamy and R Zajtchuk (1991) The management of ballistic wounds of soft tissue. R Zajtchuk, DP Jenkins, RF Bellamy, CM Quick (Eds) Textbook of Military Medicine, Part I: Warfare, Weaponry and the Casualty: Conventional Warfare-Ballistic, Blast and Burn Injuries Washington, DC: Office of the Surgeon General, Department of the Army, United States of America 163-220
6. DM Davies (1979) Gas gangrene as a complication of burns. Scand J Plastic Reconstruct Surg 13 73-75
7. WH Decker and WH Hall (1966) Treatment of abortions infected with Clostridium welchii. Am J Obstet Gynecol 95 394-399
8. JT Browne, AH Van Derhor, TS McConnell and JW Wiggins (1966) Clostridium perfringens myometritis complicating Cesarean section: Report of 2 cases. Obstet Gynecol 28 64-69
9. B Lorber (2005) Gas gangrene and other Clostridium-associated diseases. GL Mandell, JE Bennett, R Dolin (Eds) Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases 6th ed Philadelphia: Elsevier/Churchill Livingston 2828-2838
10. DL Stevens and AE Bryant (2002) The role of Clostridial toxins in the pathogenesis of gas gangrene. Clin Infect Dis 35(suppl 1), S93-S100
11. MM Awad, AE Bryant, DL Stevens and JI Rood (1995) Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas-gangrene. Mol Microbiol 15 191-202
12. RW Titball and T Rubidge (1990) The role of histidine residues in the alpha toxin of Clostridium perfringens. FEMS Microbiol Lett 56 261-265
13. RW Titball (2005) Gas gangrene: An open and shut case. Microbiology 151 2821-2828
14. C Gustafson and C Tagesson (1990) Phopholipase-C from Clostridium perfringens stimulates phopholipase-A2-mediated arachidonic acid release in cultured intestinal epithelial cells. Scand J Gastroenterol 25 363-371
15. AE Bryant, RY Chen, Y Nagata, et al. (2000) Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis 182 808-815
16. AE Bryant, RY Chen, Y Nagata, et al. (2000) Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis 182 799-807
17. RW Titball (2005) Gas gangrene: An open and shut case. Microbiology 151 2822
18. JW McNee and JS Dunn (1917) The method of spread of gas gangrene into living muscle. Br Med J 1 727-729
19. AE Bryant, MJ Bayer CR Aldape, et al. (2006) Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis. J Med Microbiol 55 495-504
20. M Bunting, DE Lorant, AE Bryant, et al. (1997) Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest 100 565-574
21. SR Thom (1993) Functional inhibition of neutrophil β2 integrins by hyperbaric oxygen in carbon monoxide mediated brain injury. Toxicol Appl Pharmacol 123 248-256
22. JD Martin and SR Thom (2002) Vascular leukocyte sequestration in decompression sickness and prophylactic hyperbaric oxygen therapy in rats. Aviat Space Environ Med 73 565-569
23. SR Thom, I Mendiguren, KR Hardy, et al. (1997) Inhibition of human neutrophil β2 integrin-dependent adherence by hyperbaric oxygen. Am J Physiol 272 C770-C777
24. DL Stevens, BE Troyer, DT Merrick, et al. (1988) Lethal effects and cardiovascular effects of purified α- and θ-toxins from Clostridium perfringens. J Infect Dis 157 272-279
25. CE Naylor, JT Eaton, A Howells, et al. (1998) Structure of the key toxin in gas gangrene. Nat Struct Biol 5 738-746
26. L Weinstein and MA Barza (1973) Gas gangrene. N Engl J Med 289 1129-1131
27. DL Stevens, DM Musher, DA Watson, et al. (1990) Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis 12 286-296
28. HM Dean, CL Decker and LD Baker (1967) Temporary survival in Clostridial hemolysis with absence of circulating red cells. N Engl J Med 277 700-701
29. AT Powers, I Jacoby, FP Lynch, et al. (1987) Adjunctive use of HBO for Clostridial myonecrosis in the newborn. Underwater and Hyperbaric Physiology IX: Proceedings of the 9th International Symposium on Underwater and Hyperbaric Physiology. Kobe, Japan September 1986 Bethesda, MD: Undersea and Hyperbaric Medical Society 1087-1092
30. DL Stevens, KA Maier and JE Mitten (1987) Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob. Agents Chemother 31 213-218
31. DJ Bakker (1988) Clostridial myonecrosis. JC Davis, TK Hunt (Eds) Problem Wounds: The Role of Oxygen New York: Elsevier Science Publishing 168-170
32. WH Brummelkamp, J Hogendijk and I Boerema (1961) Treatment of anaerobic infections (Clostridial myonecrosis) by drenching the tissues with oxygen under high atmospheric pressure. Surgery 49 299-302
33. AJM Van Unnik (1965) Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie van Leeuwenhoek 31 181-186
34. D Kaye (1967) Effect of hyperbaric oxygen on Clostridia in vitro and in vivo. Proc Soc Exp Biol Med 124 360-366
35. FJ Demello, T Hashimoto, CR Hitchcock and JJ Haglin (1970) The effect of hyperbaric oxygen on the germination and toxin production of Clostridium perfringens spores. J Wada, JT Iwa (Eds) Proceedings of the 4th International Congress on Hyperbaric Medicine Baltimore: Williams & Wilkins 270
36. FJ Demello, JJ Haglin and CR Hitchcock (1973) Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery, and hyperbaric oxygen. Surgery 73 936-941
37. HG Kelley and WG Pace (1963) Treatment of anaerobic infections in mice with hyperpressure oxygen. Surg Forum 14 46-47
38. PJ Klopper (1964) Hyperbaric oxygen treatment after ligation of the hepatic artery in rabbits. I Boerema, WH Brummelkamp, NG Meijne (Eds) Clinical Application of Hyperbaric Oxygen Amsterdam: Elsevier 31-35
39. GB Hill and S Osterhout (1972) Experimental effects of hyperbaric oxygen on selected clostridial species I. in vitro and II. In vivo studies in mice. J Infect Dis 125 17-35
40. KH Muhvich, LH Anderson and WJ Mehm (1994) Evaluation of antimicrobials combined with hyperbaric oxygen in a mouse model of clostridial myonecrosis. J Trauma 36 7-10
41. IP Unsworth and PA Sharp (1984) Gas gangrene: An 11-year review of 73 cases managed with hyperbaric oxygen. Med J Austr 140 256-260
42. FW Rudge (1993) The role of hyperbaric oxygenation in the treatment of clostridial myonecrosis. Mil Med 158 80-83
43. J Desola, E Escolé, E Moreno, et al. (1990) Combined treatment of gaseous gangrene with hyperbaric oxygen therapy, surgery and antibiotics. A national cooperative multi-center study. Med Clin (Barcelona) 94 641-650
44. K Korhonen, J Klossner, M Hirn and J Niinikowski (1999) Management of clostridial gas gangrene and the role of hyper-baric oxygen. Ann Chir Gynaecol 88 139-142
45. WA Altemeier and WD Fullen (1971) Prevention and treatment of gas gangrene. JAMA 217 806-813
46. RD Heimbach, I Boerema, WH Brummelkamp and WG Wolfe (1977) Current therapy of gas gangrene. JC Davis, TK Hunt (Eds) Hyperbaric Oxygen Therapy Bethesda, MD: Undersea Medical Society 153-165
47. DJ Bakker (2003) Clostridial myonecrosis. J Feldmeier (Eds) Hyperbaric Oxygen 2003. Indications and Results—The Hyperbaric Oxygen Therapy Committee Report Kensington, MD: Undersea and Hyperbaric Medical Society 19-25
48. EC Peirce (1984) Gas gangrene: Review and update. Surg Rounds 7 17-25
49. FL Meleney (1924) Hemolytic streptococcus gangrene. Arch Surg 9 317-364
50. B Wilson (1952) Necrotizing fasciitis. Am Surg 18 426-431
51. LG Miller, F Perdreau-Remington, G Rieg, et al. (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 1445-1453
52. TV Brogan, V Nizet, JHT Waldhausen, et al. (1995) Group A streptococcal necrotizing fasciitis complicating primary varicella: A series of fourteen patients. Pediatr Infect Dis J 14 588-594
53. A Rimailho, B Riou, C Richard and P Auzepy (1987) Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis 155 143-146
54. DM Zerr, ER Alexander, JS Duchin, et al. (1999) A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 103 783-790
55. AL Bell, H Adamson, F Kirk, et al. (1991) Diclofenac inhibits monocyte superoxide production ex vivo in rheumatoid arthritis. Rheumatol Int 11 27-30
56. RS Sawin, RT Schaller, D Tapper, et al. (1994) Early recognition of neonatal abdominal wall necrotizing fasciitis. Am J Surg 167 481-484
57. T-L Wang and C-R Hung (2004) Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. Ann Emerg Med 44 222-228
58. KP Lally, JB Atkinson, MM Wooley and GH Mahour (1984) Necrotizing fasciitis: A serious sequela of omphalitis in the newborn. Ann Surg 199 101-103
59. RS Sawin, RT Schaller, D Tapper, et al. (1994) Early recognition of neonatal abdominal wall necrotizing fasciitis. Am J Surg 167 481-484
60. I Stamenkovic and PD Lew (1984) Early recognition of potentially fatal necrotizing fasciitis: The use of frozen-section biopsy. N Engl J Med 310 1689-1693
61. MG Wysoki, TA Santora, RM Shah and AC Friedman (1997) Necrotizing fasciitis: CT characteristics. Radiology 203 859-863
62. MR Schmid, T Kossman and S Duewell (1998) Differentiation of necrotizing fasciitis and cellulitis using MR imaging. Am J Roentgenol 170 615-620
63. D Gozal, A Ziser, A Shupak, et al. (1986) Necrotizing fasciitis. Arch Surg 121 233-235
64. JA Riseman, WA Zamboni, A Curtis, et al. (1990) Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 108 847-850
65. G Mandell (1974) Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 9 337-341
66. D Wilkinson and D Doolette (2004) Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg 139 1339-1345
67. SJ Escobar, JB Slade, TK Hunt and P Cianci (2006) Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med 32 437-443
68. DR Brown, NL Davis, M Lepawsky, et al. (1994) A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 167 485-489
69. JH Monestersky and RAM Myers (1995) Hyperbaric oxygen treatment of necrotizing fasciitis [letter]. Am J Surg 169 187-188
70. RS Hollabaugh, RR Dmochowski and WL Hickerson (1998) Fournier's gangrene: Therapeutic impact of hyper-baric oxygen. Plast Reconstr Surg 101 94-100
71. R Pizzorno, F Bonini, A Donelli, et al. (1997) Hyperbaric oxygen therapy in the treatment of Fournier's disease in 11 male patients. J Urol 158 837-840
72. K Korhonen, M Him and J Niinikoski (1998) Hyperbaric oxygen in the treatment of Fournier's gangrene. Eur J Surg 164 251-255
73. E Laor, LS Palmer and BM Tolia (1995) Outcome prediction in patients with Fournier's gangrene. J Urol 154 89-92
74. P Dahm, FH Roland, SN Vaslef, et al. (2000) Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology 56 31-36
75. M Lepawsky (2003) Necrotizing soft tissue infections. JJ Feldmeier (Eds) Hyperbaric Oxygen 2003. Indications and Results—The Hyperbaric Oxygen Therapy Committee Report Kensington, MD: Undersea and Hyperbaric Medical Society 69-78
76. HH Stone and JD Martin (1972) Synergistic necrotizing cellulitis. Ann Surg 175 702-711
77. AN Bessman and W Wagner (1975) Nonclostridial gas gangrene. JAMA 233 958
78. TS Cullen (1924) A progressively enlarging ulcer of abdominal wall involving the skin and fat, following drainage of an abdominal abscess, apparently of appendiceal origin. Surg Gynecol Obstet 38 579-582
79. IM Ledingham and MA Tehrani (1975) Diagnosis, clinical course and treatment of acute dermal gangrene. Br J Surg 62 364-372
80. M Chayakulkeeree, MA Ghannoum and JR Perfect (2006) Zygo-mycosis: The re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 25 215-229
81. JS McNulty (1982) Rhinocerebral mucormycosis: Predisposing factors. Laryngoscope 92 1140-1143
82. JD Bagdade, RK Root and RJ Bulger (1974) Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23 9-15
83. CP Nielson and DA Hindson (1989) Inhibition of polymorphonu-clear leukocyte respiratory burst by elevated glucose concentration. Diabetes 38 1031-1035
84. JM Alexiewicz, D Kumar, M Smogorzewski, et al. (1995) Poly-morphonuclear leukocytes in non-insulin dependent diabetes mellitus: Abnormalities in metabolism and function. Ann Intern Med 123 919-924
85. WM Artis, JA Fountain, HK Delcher and HE Jones (1982) A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability. Diabetes 31 1109-1114
86. DW Windus, TJ Stokes, BA Julian and AZ Fenves (1987) Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. Ann Intern Med 107 678-680
87. JR Boelaert, GF Van Roost, PL Vergauwe, et al. (1988) The roled of deferoxamine in dialysis-associated mucormycosis: Report of three cases and review of the literature. Clin Nephrol 29 261-266
88. CS Cocanour, P Miller-Crouchett, RL Reed, et al. (1992) Mucormycosis in trauma patients. J Trauma 32 12-15
89. MJ Tedder, JA Spratt, MP Anstadt, et al. (1994) Pulmonary mucormycosis: Results of medical and surgical therapy. Ann Thorac Surg 57 1044-1050
90. JA Ribes, CL Vanover-Sams and DJ Baker (2000) Zygomycetes in human disease. Clin Microbiol Revs 13 236-301
91. HW Murray (1975) Pulmonary mucormycosis with massive fatal hemoptysis. Chest 68 65-68
92. DM Michalak, DR Cooney, KH Rhodes, et al. (1980) Gastrointestinal mucormycosis in infants and children: A cause of gangrenous intestinal cellulitis and perforation. J Pediatr Surg 15 320-324
93. G Chamilos, EM Marom, RE Lewis, et al. (2005) Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 41 60-66
94. RD Diamond, CC Haudenschild and NF Erickson III (1982) Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro. Infect Immun 38 292-297
95. AR Waldorf (1989) Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser 47 243-271
96. AR Waldorf, N Ruderman and RD Diamond (1984) Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 74 150-160
97. C Gil-Lamaignere, M Simitsopoulou, E Rollides, et al. (2005) Interferon-γ and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 191 1180-1187
98. AS Ibrahim, B Spellberg, V Avanessian, et al. (2005) Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun 73 778-783
99. F Imperatore, S Cuzzocrea, D De Lucia, et al. (2006) Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome. Intensive Care Med 32 1881-1888
100. JA Buras, D Holt, D Orlow, et al. (2006) Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 34 2624-2629
101. BV John, G Camilos and DP Kontoyiannis (2005) Hyperbaric oxygen as an adjunctive treatment for Zygomycosis. Clin Microbiol Infect 11 515-517
102. MM Roden, TE Zaoutis, WL Buchanan, et al. (2005) Epidemiology and outcome of Zygomycosis: A review of 929 reported cases. Clin Infect Dis 41 634-653
103. NG Almyroudis, DP Konoyiannis, KA Sepkowitz, et al. (2006) Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Clin Infect Dis 43 1449-1455
104. Y Bentur, A Shupak, Y Ramon, et al. (1998) Hyperbaric oxygen therapy for cutaneous/soft-tissue Zygomycosis complicating diabetes mellitus. Plast Reconstr Surg 102 822-824
105. ME Temple, MT Brady, KI Koranyi and MC Nahata (2001) Periorbital cellulitis secondary to Conidiobolus incongruous. Pharmacotherapy 21 351-354
106. JH Powers (2006) Salvage therapy trials in fungal disease: Challenges and opportunities. Clin Infect Dis 43 1456-1459
107. SM Trifilio, CL Bennett, PR Yarnold, et al. (2007) Breakthrough Zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 39 425-429
108. RN Greenberg, K Mullane, J-AH van Burick, et al. (2006) Posaconazole as salvage therapy for Zygomycosis. Antimicrob Agents Chemother 50 126-133
109. JD Langford, DL McCartney and RC Wang (1997) Frozen section-guided surgical debridement for management of rhino-orbital mucormycosis. Am J Ophthalmol 124 265-267